Screener
Twist Bioscience Corporation TWST Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (in thousands) | Six months ended March 31, 2026 | Six months ended March 31, 2025 |
|---|---|---|
| Proceeds from issuance under employee stock purchase plan | 2,357 | 2,429 |
| Repurchases of common stock for income tax withholding | (10) | (11) |
| Net cash provided by financing activities | $4,436 | $21,140 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $3 | $51 |
| Net decrease in cash, cash equivalents, and restricted cash | (60,573) | (16,185) |
| Cash, cash equivalents, and restricted cash at beginning of period | 185,425 | 229,132 |
| Cash, cash equivalents, and restricted cash at end of period | $124,852 | $212,947 |
| Supplemental disclosure of cash flow information |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's cash & equivalents?
- Twist Bioscience Corporation (TWST) reported cash & equivalents of $124.85M in Q1 2026.
- How has Twist Bioscience Corporation's cash & equivalents changed year-over-year?
- Twist Bioscience Corporation's cash & equivalents decreased by 41.4% year-over-year, from $212.95M to $124.85M.
- What is the long-term trend for Twist Bioscience Corporation's cash & equivalents?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's cash & equivalents has grown at a -20.6% compound annual growth rate (CAGR), from $467.36M to $185.43M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Twist Bioscience Corporation's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude